Pharmaceutical Industry

Corden Pharma Schweizerhalle GmbH 

Muttenz · Since 2025

Hemastatx GmbH 

Allschwil · Since 2025

Hemastatx GmbH develops targeted therapies for severe bleeding disorders and is advancing HMX-001, a monoclonal antibody program for von Willebrand factor (VWF)–related bleeding disorders. HMX-001 is designed to inhibit ADAMTS13 activity to preserve functional high‑molecular‑weight VWF multimers and help control bleeding episodes.

Umlaut.bio GmbH 

Basel · Since 2025

Umlaut.bio GmbH develops small‑molecule therapeutics that target specific tRNA modifications to influence signaling pathways involved in cancer and inflammatory diseases. The company’s approach focuses on inhibiting key steps in tRNA modification to prevent overactivation of multiple signaling molecules.

Corsano Health SA 

Plan-Les-Ouates · Since 2025

Corsano Health SA is a MedTech company that develops, manufactures and markets medical‑grade wearable devices and a cloud platform for continuous, real‑time patient monitoring and remote care. Its CardioWatch bracelets measure multiple vital signs (heart rate, respiratory rate, ECG, SpO2, core temperature and cuffless blood pressure), hold CE‑MDR certification and FDA 510(k) clearance, and provide APIs/SDKs and raw data access for clinical research and EMR integration.

planteamed AG 

Stallikon · Since 2025

planteamed AG is a company in the phyto-pharmaceutical sector that develops and supplies medical-grade products and related services. Its website states a focus on the international phyto-pharmaceutical market and the application of specialized expertise.

Sanofi International AG 

Rotkreuz · Since 2025

Ilonov Therapeutics SA 

Allschwil · Since 2025

Ilonov Therapeutics SA is a preclinical-stage biopharmaceutical company developing first-in-class biotherapies for diabetes and metabolic diseases by leveraging the muscle secretome and myokines; its lead program centers on the myokine candidate ILV-001, which aims to protect pancreatic islets and support therapies for type 1 and type 2 diabetes.

Baxiva AG 

Schlieren · Since 2025

Baxiva AG develops glycoconjugate vaccines for the prevention of bacterial infections. Its platform chemically links serotype-specific bacterial polysaccharides to virus-like particles (VLPs) to generate immunogenic, multivalent vaccine candidates against Gram-negative pathogens such as Escherichia coli.

ApoTalic Sàrl 

Geneva · Since 2025

ApoTalic Sàrl provides temporary pharmacy cover and pharmaceutical services, including prescription review, medication dispensing and patient counselling.

NaturMed GmbH 

Belp · Since 2025

REMUUN AG 

Zurich · Since 2025

REMUUN AG develops therapeutic monoclonal antibodies and provides research and development services using a proprietary platform called MEGA.

GaleniCare AG 

Bern · Since 2001

ABRA Sàrl 

Lausanne · Since 2010

The core activity of Abra-Pharma is to advise and support pharmaceutical, bio-pharmaceutical and biotechnology companies in the market authorization and launch of their medicines in Switzerland and the EU. This includes services such as regulatory approval consulting, market access, sales and distribution of medicines. Additionally, the company researches natural solutions for various diseases and offers innovative medical products, such as wound healing solutions and blood volume analyzers.

Absci GmbH 

Zug · Since 2022

ACROBiosystems AG 

Zug · Since 2022

ACROBiosystems AG supplies life-science reagents and services, including recombinant proteins, antibodies, cell lines, cell culture reagents and assay kits. The company also provides GMP-grade materials, custom protein services and analytical/quality-control services to support cell and gene therapy development.

AdRegeneer AG 

Basel · Since 2019

The core activity of AdRegeneer AG is the development of regenerative medicines for the nervous system, particularly for the treatment of multiple sclerosis and spinal cord injuries.

Advanced Biotech Laboratories Switzerland SA 

Geneva · Since 2010

The core activity of Advanced Biotech Laboratories Switzerland SA is the selection and promotion of high-quality anti-aging products and luxury health services, particularly in the field of cell therapy and stem cell research. The company collaborates with various clinics and laboratories to offer innovative products and services in the field of health and beauty.

AdVita Lifescience AG 

Basel · Since 2021

Agios International GmbH 

Baar · Since 2015

Alfasigma Schweiz AG 

Zofingen · Since 1990

The core activity of Alfasigma is the development, manufacture and marketing of pharmaceuticals. The focus is on research and development as well as the production of some company-owned molecules, and on developing a solid strategy of mergers and acquisitions of other companies.